Literature DB >> 12655551

The molecular basis of phenylketonuria in Latvia.

N Pronina1, S Giannattasio, P Lattanzio, R Lugovska, P Vevere, A Kornejeva.   

Abstract

Characterization of the molecular basis of phenylketonuria (PKU) in Latvia has been accomplished through the analysis of 96 unrelated chromosomes from 50 Latvian PKU patients. Phenylalanine hydroxylase (PAH) gene mutations have been analyzed through a combined approach in which R158Q, R252W, R261Q, G272X, IVS10-11G>A and R408W mutations were first screened for by PCR or restriction generating PCR amplification of PAH gene exons 5, 7, 11 and 12 followed by digestion with the appropriate diagnostic enzyme. Subsequently 'broad range' denaturing gradient gel electrophoresis analysis of the 13 PAH gene exons has been used to study uncharacterized PKU chromosomes. A mutation detection rate of 98% was achieved. 12 different mutations were found, with the most frequent mutation, R408W, accounting for 76% of Latvian PKU alleles. Six mutations (R408W, E280K, R158Q, A104D, R261Q and P281L) represent 92% of PKU chromosomes. PAH VNTR and STR alleles have been also identified and minihaplotype associations with PKU mutations were also determined. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655551     DOI: 10.1002/humu.9114

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  Hyperphenylalaninaemias in Estonia: Genotype-Phenotype Correlation and Comparative Overview of the Patient Cohort Before and After Nation-Wide Neonatal Screening.

Authors:  Hardo Lilleväli; Karit Reinson; Kai Muru; Kristi Simenson; Ülle Murumets; Tõnu Möls; Katrin Õunap
Journal:  JIMD Rep       Date:  2017-09-28

2.  Prevalence of tetrahydrobiopterine (BH4)-responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients.

Authors:  Elisabeth Sterl; Karl Paul; Eduard Paschke; Johannes Zschocke; Michaela Brunner-Krainz; Eva Windisch; Vassiliki Konstantopoulou; Dorothea Möslinger; Daniela Karall; Sabine Scholl-Bürgi; Wolfgang Sperl; Florian Lagler; Barbara Plecko
Journal:  J Inherit Metab Dis       Date:  2012-04-25       Impact factor: 4.982

3.  Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance.

Authors:  M Kreile; O Lubina; I Ozola-Zalite; R Lugovska; N Pronina; O Sterna; P Vevere; M Konika; I Malniece; L Gailite
Journal:  Mol Genet Metab Rep       Date:  2020-10-20

4.  The Molecular Bases of Phenylketonuria (PKU) in New South Wales, Australia: Mutation Profile and Correlation with Tetrahydrobiopterin (BH4) Responsiveness.

Authors:  Gladys Ho; Ian Alexander; Kaustuv Bhattacharya; Barbara Dennison; Carolyn Ellaway; Sue Thompson; Bridget Wilcken; John Christodoulou
Journal:  JIMD Rep       Date:  2013-12-25

5.  Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia.

Authors:  Polina Gundorova; Anna A Stepanova; Irina A Kuznetsova; Sergey I Kutsev; Aleksander V Polyakov
Journal:  PLoS One       Date:  2019-01-22       Impact factor: 3.240

6.  Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing.

Authors:  Nana Li; Haitao Jia; Zhen Liu; Jing Tao; Song Chen; Xiaohong Li; Ying Deng; Xi Jin; Jiaping Song; Liangtao Zhang; Yu Liang; Wei Wang; Jun Zhu
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.